TrivarX Ltd News

TrivarX Ltd: Results of Annual General Meeting

Nov 27 20:22 ET

TrivarX Ltd: Annual General Meeting - Chairman Update

Nov 27 16:21 ET

TrivarX Ltd: New AI Tool Expands Patient Reach and Market Opportunities

Nov 6 16:22 ET

TrivarX Ltd: September 2024 Quarterly Activities Report and Appendix 4C

Oct 29 23:13 ET

TrivarX Ltd: Proposed issue of securities - TRI

Oct 27 21:00 ET

TrivarX Ltd: Letter to Shareholders & Notice of AGM & Proxy Form

Oct 27 19:49 ET

TrivarX Ltd: Notice of AGM and Closing Date for Director Nominations

Oct 8 17:29 ET

TrivarX Ltd: Initial Director's Interest Notice - John Mathias

Oct 6 17:41 ET

TrivarX Ltd: Company Secures R&D Loan Facility

Sep 30 18:26 ET

TrivarX Ltd: TrivarX Appoints Leading US Healthcare Executive to Board

Sep 24 18:25 ET

TrivarX Ltd: TrivarX Requests Pre-Submission Meeting with US FDA

Sep 23 18:23 ET

TrivarX Ltd: Appendix 4G

Sep 18 18:27 ET

TrivarX Ltd: Corporate Governance Statement

Sep 18 18:27 ET

TrivarX Ltd: 2024 Annual Report

Sep 18 18:27 ET

TrivarX Ltd: Notification under Listing Rule 4.3D

Sep 18 18:22 ET

TrivarX Ltd: Appendix 4E - Preliminary Final Report

Aug 28 19:08 ET

TrivarX Ltd: Notification of cessation of securities - TRI

Aug 19 19:16 ET

TrivarX Ltd: June 2024 Quarterly Activities Report and Appendix 4C

Jul 30 23:49 ET

TrivarX Ltd: Initial Director's Interest Notice - Tony Keating

Jul 29 19:27 ET

TrivarX Ltd: Final Director's Interest Notice - Tom Young

Jul 29 19:26 ET